We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?
Jenna R. Carl, PhD
Advertisement
Dr Carl is vice president of clinical development & medical affairs at Big Health Inc.
Articles by Jenna R. Carl, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
2
Treating Mental Illness During Pregnancy the Same as Any Medical Illness: In Conversation With Jennifer L. Payne, MD
3
Exploring CBT Approaches for Chronic Insomnia in Adults: A Systematic Review and Network Meta-Analysis
4
The Use of Aripiprazole for Bipolar Disorder
5
